Skip to main
INFU

InfuSystem Hlds (INFU) Stock Forecast & Price Target

InfuSystem Hlds (INFU) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

InfuSystems Holdings Inc. reported a significant increase in gross profit for the quarter, rising by $2.2 million year-over-year to $20.4 million, with a gross margin expansion of approximately 260 basis points to 56.4%. The company's Patient Services segment contributed to an 8% growth in revenue, bolstered by a new contract with a large hospital system that is expected to enhance patient volumes. Additionally, year-to-date net operating cash flow improved to $17.3 million, reflecting a 38% increase attributed to higher earnings and improved working capital management, further underlining the company's solid financial positioning.

Bears say

InfuSystems Holdings faces a challenging financial outlook primarily due to a restructured contract with its largest biomedical services customer, which is projected to decrease annual revenue by $7.1 million in 2026 and negatively impact overall revenue estimates. Additionally, the company is experiencing margin compression and competitive pressures, compounded by potential delays in key growth drivers such as Pain Management and Wound Care, which could further hinder revenue generation and margin performance. Cash flow from operations also showed signs of decline, with a 10% year-over-year decrease in Q4, adding to concerns regarding the company’s financial stability and growth trajectory.

InfuSystem Hlds (INFU) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of InfuSystem Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About InfuSystem Hlds (INFU) Forecast

Analysts have given InfuSystem Hlds (INFU) a Strong Buy based on their latest research and market trends.

According to 2 analysts, InfuSystem Hlds (INFU) has a Strong Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

InfuSystem Hlds (INFU)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.